CWLXFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
C21 Investments Inc.
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 12, 2026
Share price
Not available yet
Price, market cap and P/E appear here once daily prices are connected.
C21 Investments Inc. grew revenue 15.3% to $32.61M over fiscal 2026. Operating income rose 54.8% to $2.28M, moving the operating margin from 5.2% to 7.0%. Free cash flow was $1.12M, down 59.2% from a year earlier.
Revenue
$32.61M
+15.3% vs. a year earlier
Operating income
$2.28M
+54.8% vs. a year earlier
Free cash flow
$1.12M
-59.2% vs. a year earlier
EPS, diluted
-$0.03
FY2026
Key statistics
Valuation at the latest close; fundamentals over fiscal 2026, balances at Mar 31, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $32.61M
- Net income
- -$3.24M
- EPS, diluted
- -$0.03
- Free cash flow
- $1.12M
Valuation needs the share price. It fills in once daily prices are connected.
Nine years at a glance
Fiscal years 2017 to 2026, USD
Revenue
$32.61M+15.3% YoY
Gross profit
$13.61M+22.0% YoY
Operating income
$2.28M+54.8% YoY
Net income
-$3.24M
EPS, diluted
-$0.03
Free cash flow
$1.12M-59.2% YoY
Reported period